SCHEMBL30168133

SCHEMBL30168133

COc1ccc(-c2cnc3c(Nc4ccc(NC(=O)CCCCBr)cc4)nccn23)cc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTK6 Q13882 1/20 0.42
▸ TTK P33981 5/20 0.42
▸ PKM P14618 1/20 0.42
▸ MAPT P10636 4/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ POLB P06746 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ HDAC3 O15379 4/20 0.38
▸ HDAC4 P56524 4/20 0.38
▸ HDAC1 Q13547 4/20 0.38
▸ HDAC7 Q8WUI4 4/20 0.38
▸ HDAC2 Q92769 4/20 0.38
▸ HDAC10 Q969S8 4/20 0.38
▸ HDAC11 Q96DB2 4/20 0.38
▸ HDAC8 Q9BY41 4/20 0.38
▸ HDAC6 Q9UBN7 4/20 0.38
▸ HDAC9 Q9UKV0 4/20 0.38
▸ HDAC5 Q9UQL6 4/20 0.38
▸ EGFR P00533 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25167794 0.88 PTK6 (0.46) PTK6TTKMAPTRXFP1ALDH1A1
SCHEMBL30168204 0.88 PTK6 (0.46) PTK6TTKMAPTRXFP1ALDH1A1
SCHEMBL24105218 0.86 PTK6 (0.47) PTK6TTKALDH1A1EGFRERBB2
SCHEMBL25170919 0.83 PTK6 (0.42) PTK6TTKMAPTRXFP1POLB
SCHEMBL22139065 0.83 MAPKAPK5 (0.54) PTK6TTKEGFRKDRMAPKAPK5
SCHEMBL30172072 0.82 TTK (0.52) PTK6TTKMAPKAPK5
SCHEMBL22122908 0.82 TTK (0.52) PTK6TTKMAPKAPK5
SCHEMBL24104736 0.82 PTK6 (0.41) PTK6TTKMAPTRXFP1ALDH1A1
SCHEMBL24105205 0.82 KDR (0.48) PTK6MAPTNPSR1ALDH1A1EGFR
SCHEMBL30167861 0.82 PTK6 (0.41) PTK6TTKMAPTRXFP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115667264-A Novel imidazo-pyrazine derivatives 豪夫迈·罗氏有限公司 2023-01-31 — — CN disclosed
Send feedback